| For: | Lu C, Xu CF, Wan XY, Zhu HT, Yu CH, Li YM. Screening for pancreatic cancer in familial high-risk individuals: A systematic review. World J Gastroenterol 2015; 21(28): 8678-8686 [PMID: 26229410 DOI: 10.3748/wjg.v21.i28.8678] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i28/8678.htm |
| Number | Citing Articles |
| 1 |
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Adenocarcinoma ductal de páncreas. Experiencia de 11 años en un centro de tercer nivel. Revista de Gastroenterología de México 2021; 86(2) doi: 10.1016/j.rgmx.2020.04.004
|
| 2 |
Kristine McCarthy, Wei Zhang, Danilo Lovinaria, Jose Soliz. Oncologic Critical Care. 2026; doi: 10.1007/978-3-319-74698-2_180-2
|
| 3 |
Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti. BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives. Cancers 2020; 12(11) doi: 10.3390/cancers12113346
|
| 4 |
Alexandra R Lewis, Juan W Valle, Mairead G McNamara. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?. World Journal of Gastroenterology 2016; 22(32): 7175-7185 doi: 10.3748/wjg.v22.i32.7175
|
| 5 |
Penpa Dorjee, Zi-Wen Long. A mixed treatment comparison of toxicity of gemcitabine combined with different targeted drugs in the treatment of advanced or metastatic pancreatic cancer. Cancer Biology & Therapy 2018; 19(6) doi: 10.1080/15384047.2018.1433503
|
| 6 |
Divyanshoo R. Kohli, Ken Robert Smith, Jathine Wong, Zhe Yu, Kenneth Boucher, Douglas O. Faigel, Rahul Pannala, Randall W. Burt, Karen Curtin, N. Jewel Samadder. Familial pancreatic cancer risk: a population-based study in Utah. Journal of Gastroenterology 2019; 54(12) doi: 10.1007/s00535-019-01597-3
|
| 7 |
Wataru Gonoi, Takana Yamakawa Hayashi, Hidemi Okuma, Masaaki Akahane, Yousuke Nakai, Suguru Mizuno, Ryosuke Tateishi, Hiroyuki Isayama, Kazuhiko Koike, Kuni Ohtomo. Development of pancreatic cancer is predictable well in advance using contrast-enhanced CT: a case–cohort study. European Radiology 2017; 27(12) doi: 10.1007/s00330-017-4895-8
|
| 8 |
Eli Marie Grindedal, Manuela Zucknick, Sigrid Tronsli Hovland, Tom K. Grimsrud, Lovise Mæhle. A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2. BJC Reports 2025; 3(1) doi: 10.1038/s44276-025-00199-2
|
| 9 |
Ji Kon Ryu. The Early Detection of Pancreatic Cancer: Whom and How?. Korean Journal of Pancreas and Biliary Tract 2015; 20(4) doi: 10.15279/kpba.2015.20.4.198
|
| 10 |
Tanya Dwarte, Skye McKay, Amber Johns, Katherine Tucker, Allan D. Spigelman, David Williams, Alina Stoita. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Hereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0129-1
|
| 11 |
Thomas Hank, Oliver Strobel. Conversion Surgery for Advanced Pancreatic Cancer. Journal of Clinical Medicine 2019; 8(11) doi: 10.3390/jcm8111945
|
| 12 |
Akihiro Ohmoto, Shinichi Yachida, Chigusa Morizane. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(3) doi: 10.3390/ijms20030561
|
| 13 |
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care. 2019; doi: 10.1007/978-3-319-74698-2_180-1
|
| 14 |
Kasper A. Overbeek, Djuna L. Cahen, Marco J. Bruno. The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals. Familial Cancer 2024; 23(3) doi: 10.1007/s10689-024-00380-5
|
| 15 |
Hideyuki Fukui, Hiromitsu Onishi, Atsushi Nakamoto, Takahiro Tsuboyama, Takashi Ota, Keigo Yano, Yukihiro Enchi, Daisaku Yamada, Yu Takeda, Shogo Kobayashi, Yasunari Fukuda, Hidetoshi Eguchi, Takahiro Matsui, Mitsuaki Tatsumi, Noriyuki Tomiyama. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer. European Journal of Radiology 2022; 156 doi: 10.1016/j.ejrad.2022.110522
|
| 16 |
Tianle Zou, Dan Shi, Weiwei Wang, Guoyong Chen, Xianbin Zhang, Yu Tian, Peng Gong, Jinghua Pan. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic Cancer. Mediators of Inflammation 2023; 2023 doi: 10.1155/2023/5565054
|
| 17 |
Priyanka Jha, Benjamin M. Yeh, Ronald Zagoria, Eric Collisson, Zhen J. Wang. The Role of MR Imaging in Pancreatic Cancer. Magnetic Resonance Imaging Clinics of North America 2018; 26(3) doi: 10.1016/j.mric.2018.03.004
|
| 18 |
R. S. O’Neill, B. Meiser, S. Emmanuel, D. B. Williams, A. Stoita. Long-term positive psychological outcomes in an Australian pancreatic cancer screening program. Familial Cancer 2020; 19(1) doi: 10.1007/s10689-019-00147-3
|
| 19 |
Jia-Qi Zhou, Zi-Xian Liu, Hong-Fa Zhong, Guan-Qiao Liu, Ming-Cong Ding, Yu Zhang, Bin Yu, Nan Jiang. Single nucleotide polymorphisms in the development of osteomyelitis and prosthetic joint infection: a narrative review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1444469
|
| 20 |
Federico Salom, Frédéric Prat. Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer. World Journal of Gastrointestinal Endoscopy 2022; 14(1): 35-48 doi: 10.4253/wjge.v14.i1.35
|
| 21 |
Sung Bum Kim. Model to Stratify Risk of Pancreatic Cancer in Patients Diagnosed as New-onset Diabetes. The Korean Journal of Gastroenterology 2018; 72(3) doi: 10.4166/kjg.2018.72.3.159
|
| 22 |
Julia Benzel, Volker Fendrich. Familial Pancreatic Cancer. Oncology Research and Treatment 2018; 41(10) doi: 10.1159/000493473
|
| 23 |
Ankit Chhoda, Lingeng Lu, Barbara M. Clerkin, Harvey Risch, James J. Farrell. Current Approaches to Pancreatic Cancer Screening. The American Journal of Pathology 2019; 189(1) doi: 10.1016/j.ajpath.2018.09.013
|
| 24 |
Jingjing Lyu, Xin Guan, Yuhan Zhou, Huan Guo, Shanshan Cheng, Chaolong Wang. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng‐Tongji cohort. Journal of Evidence-Based Medicine 2023; 16(1) doi: 10.1111/jebm.12516
|
| 25 |
Joan Llach, Paula Aguilera, Ariadna Sánchez, Angels Ginès, Glòria Fernández-Esparrach, Guillem Soy, Oriol Sendino, Eva Vaquero, Sabela Carballal, Fabio Ausania, Juan Ramón Ayuso, Anna Darnell, María Pellisé, Sergi Castellví-Bel, Susana Puig, Francesc Balaguer, Leticia Moreira. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. Cancers 2023; 15(6) doi: 10.3390/cancers15061690
|
| 26 |
Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff. Pancreatic cancer. The Lancet 2020; 395(10242) doi: 10.1016/S0140-6736(20)30974-0
|
| 27 |
Elisabeth King, Bita Nehoray. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families. Clinical Journal of Oncology Nursing 2019; 23(6) doi: 10.1188/19.CJON.579-582
|
| 28 |
Chris M. Lindquist, Frank H. Miller, Nancy A. Hammond, Paul Nikolaidis. Pancreatic cancer screening. Abdominal Radiology 2018; 43(2) doi: 10.1007/s00261-017-1308-z
|
| 29 |
Juan E. Corral, Ananya Das, Marco J. Bruno, Michael B. Wallace. Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals. Pancreas 2019; 48(4) doi: 10.1097/MPA.0000000000001268
|
| 30 |
R. Vera, A. Ferrández, C. J. Ferrer, C. Flores, C. Joaquín, S. López, T. Martín, E. Martín, M. Marzo, A. Sarrión, E. Vaquero, A. Zapatero, J. Aparicio. Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Clinical and Translational Oncology 2017; 19(7) doi: 10.1007/s12094-016-1609-7
|
| 31 |
Amr F. Mourad, Mona M. Sayed, Hussein Fakhry. Is magnetic resonance diffusion-weighted imaging superior in the diagnosis of pancreatic adenocarcinoma and does it have a prognostic value?. The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(4) doi: 10.1016/j.ejrnm.2018.06.001
|
| 32 |
Elisabeth Maurer, Detlef K. Bartsch. Surgical aspects related to hereditary pancreatic cancer. Familial Cancer 2024; 23(3) doi: 10.1007/s10689-024-00384-1
|
| 33 |
Kai Jia, Steven Kundrot, Matvey B. Palchuk, Jeff Warnick, Kathryn Haapala, Irving D. Kaplan, Martin Rinard, Limor Appelbaum. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data. eBioMedicine 2023; 98 doi: 10.1016/j.ebiom.2023.104888
|
| 34 |
Elena M. Stoffel, Shannon E. McKernin, Randall Brand, Marcia Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M. Petersen, Diane M. Simeone, Matthew Yurgelun, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. Journal of Clinical Oncology 2019; 37(2) doi: 10.1200/JCO.18.01489
|
| 35 |
Louis de Mestier, Jean-Baptiste Danset, Cindy Neuzillet, Vinciane Rebours, Jérôme Cros, Nadem Soufir, Pascal Hammel. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers. Endocrine-Related Cancer 2016; 23(10) doi: 10.1530/ERC-16-0269
|
| 36 |
Negar Khoshghamat, Niloufar Jafari, Vajiheh Toloue-pouya, Shakiba Azami, Seyyedeh Helya Mirnourbakhsh, Majid Khazaei, Gordon A. Ferns, Majid Rajabian, Amir Avan. The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer. Life Sciences 2021; 270 doi: 10.1016/j.lfs.2021.119118
|
| 37 |
|
| 38 |
Diedron Lewis, Laura Jiménez, Kelvin K. Chan, Susan Horton, William W. L. Wong. A Systematic Review of Cost-Effectiveness Studies on Pancreatic Cancer Screening. Current Oncology 2025; 32(4) doi: 10.3390/curroncol32040225
|
| 39 |
M.-P. Vullierme, M. Lagadec. Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ?. Journal de Radiologie Diagnostique et Interventionnelle 2016; 97(5) doi: 10.1016/j.jradio.2016.10.003
|
| 40 |
Jérôme Schwingel, Miriam Decker, Lisa Schneider, Carsten Johannes Stürmer, Manfred P. Lutz. Early Detection of Pancreatic Cancer. Oncology Research and Treatment 2023; 46(6) doi: 10.1159/000530790
|
| 41 |
Olga Partyka, Monika Pajewska, Daria Kwaśniewska, Aleksandra Czerw, Andrzej Deptała, Michał Budzik, Elżbieta Cipora, Izabela Gąska, Lucyna Gazdowicz, Aneta Mielnik, Katarzyna Sygit, Marian Sygit, Edyta Krzych-Fałta, Daria Schneider-Matyka, Szymon Grochans, Anna M. Cybulska, Jarosław Drobnik, Ewa Bandurska, Weronika Ciećko, Piotr Ratajczak, Karolina Kamecka, Michał Marczak, Remigiusz Kozłowski. Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations. Cancers 2023; 15(14) doi: 10.3390/cancers15143634
|
| 42 |
Kjetil Søreide, Warsan Ismail, Marcus Roalsø, Jacob Ghotbi, Claudia Zaharia. Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery. Cancer Control 2023; 30 doi: 10.1177/10732748231154711
|
| 43 |
I.J.M. Levink, D.C.F. Klatte, R.G. Hanna-Sawires, G.C.M. Vreeker, I.S. Ibrahim, Y.E.M. van der Burgt, K.A. Overbeek, B.D.M. Koopmann, D.L. Cahen, G.M. Fuhler, M. Wuhrer, B.A. Bonsing, R.A.E.M. Tollenaar, F.P. Vleggaar, H.F.A. Vasen, M.E. van Leerdam, M.J. Bruno, W.E. Mesker. Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals. Pancreatology 2022; 22(4) doi: 10.1016/j.pan.2022.03.021
|
| 44 |
Isaura S. Ibrahim, Hans F. A. Vasen, Martin N. J. M. Wasser, Shirin Feshtali, Bert A. Bonsing, Hans Morreau, Akin Inderson, Wouter H. de Vos tot Nederveen Cappel, Wilbert B. van den Hout. Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort. United European Gastroenterology Journal 2023; 11(2) doi: 10.1002/ueg2.12360
|
| 45 |
Elena M. Stoffel, Shannon E. McKernin, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary. Journal of Oncology Practice 2019; 15(2) doi: 10.1200/JOP.18.00629
|
| 46 |
Ankit Chhoda, Ziga Vodusek, Kapil Wattamwar, Eric Mukherjee, Craig Gunderson, Alyssa Grimshaw, Anup Sharma, Nita Ahuja, Fay Kastrinos, James J. Farrell. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis. Gastroenterology 2022; 162(3) doi: 10.1053/j.gastro.2021.11.021
|
| 47 |
Juan Pablo Hinestrosa, Rosalie C. Sears, Harmeet Dhani, Jean M. Lewis, Gregor Schroeder, Heath I. Balcer, Dove Keith, Brett C. Sheppard, Razelle Kurzrock, Paul R. Billings. Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma. Communications Medicine 2023; 3(1) doi: 10.1038/s43856-023-00351-4
|
| 48 |
Griffin P. J. McNamara, Karla N. Ali, Shraddha Vyas, Tri Huynh, Monica Nyland, Deanna Almanza, Christine Laronga, Jason Klapman, Jennifer B. Permuth. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center. Gastrointestinal Disorders 2018; 1(1) doi: 10.3390/gidisord1010008
|
| 49 |
Katherina P. Farr, Daniel Moses, Koroush S. Haghighi, Phoebe A. Phillips, Claudia M. Hillenbrand, Boon H. Chua. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities. Cancers 2022; 14(10) doi: 10.3390/cancers14102539
|
| 50 |
Juan E. Corral, Karl F. Mareth, Douglas L. Riegert-Johnson, Ananya Das, Michael B. Wallace. Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies. Clinical Gastroenterology and Hepatology 2019; 17(1) doi: 10.1016/j.cgh.2018.04.065
|
| 51 |
Akiko Kowada. Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in Japan. Pancreas 2020; 49(8) doi: 10.1097/MPA.0000000000001614
|
| 52 |
M.-P. Vullierme, M. Lagadec. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?. Diagnostic and Interventional Imaging 2016; 97(12) doi: 10.1016/j.diii.2016.08.018
|
| 53 |
Uwe Pelzer. Pankreaskarzinom – Therapiestandards und spezielle Situationen. best practice onkologie 2018; 13(5) doi: 10.1007/s11654-018-0098-2
|
| 54 |
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care. 2020; doi: 10.1007/978-3-319-74588-6_180
|
| 55 |
Jonathan Kandiah, Tammy Lo, Dugho Jin, Landon Melchior, Thorsten L. Krebs, Naveen Anand, Susan Ingram, Pramila Krumholtz, Deep Pandya, Antolin Trinidad, Xiang (Eric) Dong, Ramanathan Seshadri, James Bauman, Ronald Lee, Richard C. Frank. A Community-Based Pancreatic Cancer Screening Study in High-Risk Individuals: Preliminary Efficacy and Safety Results. Clinical and Translational Gastroenterology 2022; 13(8) doi: 10.14309/ctg.0000000000000516
|
| 56 |
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
|
| 57 |
Hiroki Sato, Andrew Scott Liss, Yusuke Mizukami. Large-duct pattern invasive adenocarcinoma of the pancreas–a variant mimicking pancreatic cystic neoplasms: A minireview. World Journal of Gastroenterology 2021; 27(23): 3262-3278 doi: 10.3748/wjg.v27.i23.3262
|
| 58 |
Salvatore Paiella, Erica Secchettin, Gabriella Lionetto, Livia Archibugi, Danila Azzolina, Fabio Casciani, Diane M. Simeone, Kasper A. Overbeek, Michael Goggins, James Farrell, Ruggero Ponz de Leon Pisani, Maddalena Tridenti, Maria Assunta Corciulo, Giuseppe Malleo, Paolo Giorgio Arcidiacono, Massimo Falconi, Dario Gregori, Claudio Bassi, Roberto Salvia, Gabriele Capurso. Surveillance of Individuals at High Risk of Developing Pancreatic Cancer. Annals of Surgery 2024; 279(1) doi: 10.1097/SLA.0000000000006094
|
| 59 |
Kari G. Rabe, Maria A. Stevens, Amanda Toledo Hernández, Shruti Chandra, Joleen M. Hubbard, Jennifer L. Kemppainen, Shounak Majumder, Gloria M. Petersen. Pancreatic cancer risk to siblings of probands in bilineal cancer settings. Genetics in Medicine 2022; 24(5) doi: 10.1016/j.gim.2022.01.016
|
| 60 |
Elisabeth Maurer, Bettina Lehman, Elvira Matthäi, Ulrike Denzer, Jens Figiel, Moritz Jesinghaus, Emily P. Slater, Ulrich Stefenelli, Thomas M. Gress, Detlef K. Bartsch. Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant‐negative familial pancreatic cancer families. United European Gastroenterology Journal 2024; 12(9) doi: 10.1002/ueg2.12631
|
| 61 |
Lauren Fried, Andrea Tan, Shirin Bajaj, Tracey N. Liebman, David Polsky, Jennifer A. Stein. Technological advances for the detection of melanoma. Journal of the American Academy of Dermatology 2020; 83(4) doi: 10.1016/j.jaad.2020.03.122
|
| 62 |
Tian-Bao Yan, Jia-Qi Huang, Shi-Yun Huang, Bhavesh K. Ahir, Long-Man Li, Zeng-Nan Mo, Jian-Hong Zhong. Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.801173
|
| 63 |
N. A. Surkov, O. M. Dondup, D. A. Rudkovskaya. Endoscopic stenting of bile and pancreatic ducts in pancreatic head cancer complicated by obstructive jaundice: A clinical case. Pacific Medical Journal 2025; (3) doi: 10.34215/1609-1175-2025-3-77-82
|
| 64 |
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(5) doi: 10.3390/ijms22052655
|
| 65 |
Robert Wittram, Hans-Helmut König, Christian Brettschneider. Economic evaluations of pancreatic cancer screening: a systematic review protocol. BMJ Open 2024; 14(8) doi: 10.1136/bmjopen-2024-087003
|
| 66 |
Neeraj Patel, Aditi Gupta, Riya Mishra, Soumya V. Menon, Subhashree Ray, Surya Nath Pandey, Kavita Goyal, Haider Ali, Chandana Maji, A. Rekha, Gaurav Gupta, Md Sadique Hussain. Mesothelin in pancreatic cancer: clinical applications and analytical considerations. Clinica Chimica Acta 2026; 579 doi: 10.1016/j.cca.2025.120686
|
| 67 |
Natalia Khalaf, Basim Ali. New-onset Diabetes as a Signpost of Early Pancreatic Cancer: The Role of Screening. Clinical Gastroenterology and Hepatology 2022; 20(9) doi: 10.1016/j.cgh.2022.02.015
|
| 68 |
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Pancreatic ductal adenocarcinoma: Eleven years of experience at a tertiary care hospital center. Revista de Gastroenterología de México (English Edition) 2021; 86(2) doi: 10.1016/j.rgmxen.2020.04.005
|
| 69 |
|
| 70 |
Louis de Mestier, Marie Muller, Jérôme Cros, Marie-Pierre Vullierme, Dewi Vernerey, Frédérique Maire, Safi Dokmak, Vinciane Rebours, Alain Sauvanet, Philippe Lévy, Pascal Hammel. Appropriateness of pancreatic resection in high‐risk individuals for familial pancreatic ductal adenocarcinoma: a patient‐level meta‐analysis and proposition of the Beaujon score. United European Gastroenterology Journal 2019; 7(3) doi: 10.1177/2050640618824910
|